Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Apellis Pharmaceuticals (1JK.F) Q1 2025 Earnings
1JK.F
28
Feb
Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.5
-0.43
-0.35
-0.27
Details
Expected EPS
-0.3560145468
Actual EPS
-0.27944399999999997
Surprise EPS
0.08
Surprise Percent
+21.51%
Description
Apellis Pharmaceuticals (1JK.F) has reported earnings of -0.27944399999999997 per share for Q1 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login